ChemoCentryx
CCXI
#3558
Rank
โ‚ฌ3.20 B
Marketcap
44,60ย โ‚ฌ
Share price
0.00%
Change (1 day)
21.19%
Change (1 year)

Earnings for ChemoCentryx (CCXI)

Earnings in 2022 (TTM): -โ‚ฌ0.12 Billion

According to ChemoCentryx's latest financial reports the company's current earnings are โ‚ฌ37.2 Million. In 2021 the company made an earning of -โ‚ฌ0.12 Billion a decrease over its 2020 earnings that were of -โ‚ฌ45.22 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for ChemoCentryx from 2011 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -โ‚ฌ0.12 Billion6.49%
2021 -โ‚ฌ0.12 Billion144.84%
2020 -โ‚ฌ45.22 Million-1.18%
2019 -โ‚ฌ45.76 Million45.17%
2018 -โ‚ฌ31.52 Million-305.69%
2017 โ‚ฌ15.32 M-144.7%
2016 -โ‚ฌ34.29 Million-15.52%
2015 -โ‚ฌ40.58 Million0.85%
2014 -โ‚ฌ40.24 Million21.47%
2013 -โ‚ฌ33.13 Million-1.24%
2012 -โ‚ฌ33.54 Million906.88%
2011 -โ‚ฌ3.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚ฌ1.63 B-1,557.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.42 B-1,371.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.99 B-7,238.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-6,250.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ27.78 B-24,905.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.07 B-6,412.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.16 B-9,175.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B-1,456.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
โ‚ฌ19.80 B-17,779.94%๐Ÿ‡บ๐Ÿ‡ธ USA